Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorBusch, Galina
dc.contributor.authorBaumann, Stephan
dc.contributor.authorJitschin, Regina
dc.contributor.authorIraola, Josu
dc.contributor.authorBlumenberg , Viktoria
dc.contributor.authorGallur, Laura
dc.contributor.authorBarba, Pere
dc.contributor.authorIACOBONI, GLORIA
dc.date.accessioned2024-01-11T07:57:08Z
dc.date.available2024-01-11T07:57:08Z
dc.date.issued2023-11-28
dc.identifier.citationBlumenberg V, Busch G, Baumann S, Jitschin R, Iacoboni G, Gallur L, et al. Early quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL. Blood Adv. 2023 Nov 28;7(22):6844–9.
dc.identifier.issn2473-9529
dc.identifier.urihttps://hdl.handle.net/11351/10816
dc.descriptionCèl·lules T CAR; Citometria de flux
dc.description.sponsorshipThe work was supported by a German Research Council research grant provided within the Sonderforschungsbereich Transregio SFB-TRR 388/1 2021 452881907, and German Research Council research grant 451580403 (M.S.). The work was further supported by the Bavarian Elite Graduate Training Network (M.S. and G.B.), the Wilhelm Sander-Stiftung (M.S.) (project no. 2018.087.1), the Else Kröner-Fresenius-Stiftung (V.B., K.R., V.L.B., and M.S.), the German Cancer Consortium (V.B.), the German Cancer Aid (F.M.) (grant 70113695), the Interdisciplinary Center for Clinical Research at the University Hospital of the University of Erlangen-Nuremberg (S.V.) (project no. D43), and the Bavarian Center for Cancer Research.
dc.language.isoeng
dc.publisherThe American Society of Hematology
dc.relation.ispartofseriesBlood Advances;7(22)
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.sourceScientia
dc.subjectCèl·lules B - Tumors
dc.subjectLimfomes
dc.subjectCèl·lules T
dc.subjectAntígens - Receptors
dc.subject.meshLymphoma, Large B-Cell, Diffuse
dc.subject.meshFlow Cytometry
dc.subject.meshReceptors, Antigen, T-Cell
dc.titleEarly quantification of anti-CD19 CAR T cells by flow cytometry predicts response in R/R DLBCL
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1182/bloodadvances.2023010364
dc.subject.decslinfoma de células B grandes difuso
dc.subject.decscitometría de flujo
dc.subject.decsreceptores de antígenos de linfocitos T
dc.relation.publishversionhttps://doi.org/10.1182/bloodadvances.2023010364
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Blumenberg V] Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany. Laboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany. German Cancer Consortium (DKTK), partner site Munich, Munich, Germany. Bavarian Center for Cancer Research (BZKF), partner site Munich, Munich, Germany. [Busch G, Baumann S] Laboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany. [Jitschin R] Department of Internal Medicine 5, Hematology and Oncology, Friedrich-Alexander-Universität Erlangen-Nürnberg and University Hospital Erlangen, Erlangen, Germany. Department for Hematology and Oncology, Otto-von-Guericke University, Magdeburg, Germany. [Iacoboni G, Gallur L, Barba P] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain. Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Iraola-Truchuelo J] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Experimental Hematology, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
dc.identifier.pmid37748131
dc.identifier.wos001113825800001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Portada del document
Portada del document

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple